Cianci Vito, Zanatta Mirko
Department of Emergency, University of Padova, Italy.
Department of Emergency, Arzignano Hospital, Vicenza, Italy.
J Cardiovasc Echogr. 2020 Oct;30(Suppl 2):S6-S10. doi: 10.4103/jcecho.jcecho_50_20. Epub 2020 Oct 27.
Lung ultrasound (LUS) is one of the most important and innovative applications in emergency and critical care medicine for the management of critically ill patients. Ultrasound has been widely used in the COVID-19 pandemic as an extremely reliable technique and has proved to have a key role in the diagnosis and monitoring of patients with acute respiratory failure. The diagnostic accuracy of LUS is higher than chest X-ray and similar to computed tomography, which is considered the gold standard. COVID-19 pneumonia has some distinctive ultrasonographic signs but not pathognomonic, and LUS significantly improves the management of COVID-19 patients speeding up the diagnostic path. The examination is bedside; reduces the risk of contamination, avoiding mobilization of the patients; cuts down the amount of radioactive exposure; and gives real-time answers to many diagnostic and therapeutic doubts. Finally, the instruments are small and the scanner and the probes can be protected from contamination easily.
肺部超声(LUS)是急诊和重症医学中用于危重症患者管理的最重要且最具创新性的应用之一。超声作为一种极其可靠的技术,在新冠疫情中得到了广泛应用,并且已证明在急性呼吸衰竭患者的诊断和监测中发挥关键作用。LUS的诊断准确性高于胸部X光,与被视为金标准的计算机断层扫描相似。新冠病毒肺炎有一些独特的超声征象,但并非特异性的,LUS显著改善了新冠患者的管理,加快了诊断进程。该检查可在床边进行;降低了污染风险,避免患者移动;减少了放射性暴露量;并能实时解答许多诊断和治疗方面的疑问。最后,设备体积小,扫描仪和探头易于防护以免受污染。